Cyril Berthet

Outlook Microsoft Office 365 Pardot Linkedin Marketing Solutions DoubleClick Conversion Hotjar Google Dynamic Remarketing DoubleClick Apache WordPress.org Google Tag Manager Mobile Friendly AI

kinase inhibitor drug biomarker discovery novel inflammatory target based drug discovery oncology advanced in vitro & in vivo pharmacology immunomodulation in oncology dmpk adme medicinal chemistry bioanalysis translational biomarkers biobanking biodecontamination biosafety drug discovery drug analysis biopharma partnering inflammatory diseases infectious diseases vitro assay development vivo models biotechnology research cro in vitro biology formulation immunogenicity biomarkers bioconjugation radiochemistry in vivo pharmacology in vivo imaging oncology immuno-oncology tumor models orthotopic models metastatic models humanized models single mouse preclinical trial mrt inflammation autoimmunity models dermal models gut models kidney models liver models lung models systemic inflammation models covid-19 arboviruses influenza a/h1n1 microbiome target identification target validation integrated drug discovery preclinical pharmacology therapeutics pharmaco-imaging toxicity cmc clinical protocol biologics single agent therapies multi-modality approaches theranostics therapeutic targets clinical trials fast cycle times preclinical services translational medicine small molecule development protacs molecular radiotherapy biologics development proof of concept studies covid-19 research drug metabolism pharmacokinetics microbiome evaluation precision medicine pharmaceutical research biotechnology contract research organization therapeutic innovation ind filing translational pharmacology in vitro pharmacology global presence r&d programs therapeutic resistance innovative therapies scientific excellence collaboration drive platform cancer treatments autoimmune diseases advanced platforms therapeutic target patient-centric solutions hospital & health care health care health wellness & fitness